Original language | English |
---|---|
Journal | Allergy: European Journal of Allergy and Clinical Immunology |
DOIs | |
Publication status | Accepted/In press - 2023 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Allergy: European Journal of Allergy and Clinical Immunology, 2023.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - EAACI task force report
T2 - A consensus protocol for the basophil activation test for collaboration and external quality assurance
AU - Pascal, Mariona
AU - Edelman, S. M.
AU - Nopp, A.
AU - Möbs, C.
AU - Geilenkeuser, W. J.
AU - Knol, E. F.
AU - Ebo, D. G.
AU - Mertens, C.
AU - Shamji, M. H.
AU - Santos, A. F.
AU - Patil, S.
AU - Eberlein, B.
AU - Mayorga, C.
AU - Hoffmann, H. J.
N1 - Funding Information: M Pascal, SM Edelman, A Nopp, C Möbs, EF Knol, and C Mayorga have no conflict of interest regarding this work. B Eberlein received methodological and technical support from the company BUEHLMANN Laboratories AG (Schönenbuch, Switzerland) outside the submitted work. Dr Hoffmann reports a grant from the Innovation Fund of Denmark, outside the submitted work. Dr. Patil reports grants from the NIH (5R01AI155630, 1R21AI159732), Food Allergy Science Initiative (FASI), NIAID Immune Tolerance Network (ITN), and Charles H. Hood Foundation Child Health Award. Dr Shamji reports grants awarded to institution from the Immune Tolerance Network, UK Medical Research Council, Allergy Therapeutics, LETI Laboratories, Revolo biotherapeutics and Angany Inc. He has received consulting fees from Bristol Meyers Squibb and lecture fees from Allergy Therapeutics and LETI laboratories, all outside the submitted work. Dr. Santos reports grants from Medical Research Council (MR/M008517/1; MC/PC/18052; MR/T032081/1), Food Allergy Research and Education (FARE), the NIH, Asthma UK (AUK‐BC‐2015‐01), the Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID, NIH), and the NIHR through the Biomedical Research Centre (BRC) award to Guy's and St Thomas' NHS Foundation Trust, during the conduct of the study; speaker or consultancy fees from Thermo Scientific, Nutricia, Infomed, Novartis, Allergy Therapeutics, IgGenix, Stallergenes, Buhlmann, as well as research support from Buhlmann and Thermo Fisher Scientific through a collaboration agreement with King's College London, outside the submitted work. Dr Geilenkeuser is an employee of Referenizinstitut für Bioanalytik, DE that provided logistic assistance and reagent support for the study. Funding Information: This work was funded by Task forces from EAACI.
PY - 2023
Y1 - 2023
UR - http://www.scopus.com/inward/record.url?scp=85173537250&partnerID=8YFLogxK
U2 - 10.1111/all.15907
DO - 10.1111/all.15907
M3 - Article
C2 - 37795777
AN - SCOPUS:85173537250
SN - 0105-4538
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
ER -